Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Withdrawn 1

Sponsor Class

OTHER 7OTHER_GOV 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 11Colorectal Neoplasms 3Carcinoma, Hepatocellular 3Uterine Cervical Neoplasms 2Vomiting 1Ulcer 1Stomatitis 1Skin Cancer Face 1Recurrence 1Pathologic Complete Response 1Parasomnias 1Pain, Intractable 1Ovarian Neoplasms 1Opportunistic Infections 1Neoplasm Metastasis 1Nausea 1Melanoma 1Medulloblastoma 1Lung Neoplasms 1Leukemia, Myeloid, Accelerated Phase 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Kidney Neoplasms 1Inflammation 1Hepatitis C, Chronic 1Hepatitis C 1Hematologic Neoplasms 1Glioblastoma 1Fatigue 1Esophageal Neoplasms 1Epstein-Barr Virus Infections 1

Interventions

Nivolumab 1Immune Checkpoint Inhibitors 1Fecal Microbiota Transplantation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × OTHER_GOV × Adenocarcinoma Of Esophagus × Clear all
NCT05001360 2021-10-27

Study of FMT Combined With Nivolumab in Gastric Cancer

Fujian Cancer Hospital

Phase NA Withdrawn
Gastrointestinal

Adenocarcinoma Of Esophagus

Data powered by HemOnc (CC BY 4.0) Colophon âš¡